The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Abstract
The induction of hypoxia-inducible factor 1 (HIF-1) activity, either as a result of intratumoral hypoxia or loss-of-function mutations in the VHL gene, leads to a dramatic reprogramming of cancer cell metabolism involving increased glucose transport into the cell, increased conversion of glucose to pyruvate, and a concomitant decrease in mitochondrial metabolism and mitochondrial mass. Blocking these adaptive metabolic responses to hypoxia leads to cell death due to toxic levels of reactive oxygen species. Targeting HIF-1 or metabolic enzymes encoded by HIF-1 target genes may represent a novel therapeutic approach to cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF-1α also activates metabolic genes, such as PGK-1 and PFK1A, which increase glycolysis for ATP production during hypoxia (Semenza, 2009).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Semenza, 2009
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
Self-citationRetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Self-citation
Cited by
Sorted by citations
Items 401–475 of 475
Pulmonary Hypertension as a Metabolic Disease
Fessel, J. P., & Oldham, W. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-23594-3_8 · Cited by 1
Demirel, S. (2017) · International Journal of Hematology and Oncology · doi:10.4999/uhod.171674 · Cited by 1
Les nouvelles cibles thérapeutiques dans le cancer du rein
Méric, J., Billemont, B., & Rixe, O. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1070 · Cited by 1
Cheng, K., Yuan, Y., Liu, J., Wang, V. S., Hua, Y. I., Zm, J., Han, Y., Hg, S., & Zl, Y. (2017) · Chemotherapy Open access · doi:10.4172/2167-7700.1000243 · Cited by 1
Moiseenko, V., Bowen, S. R., Kirkpatrick, J. P., Jeraj, R., & Marks, L. B. (2018) · CRC Press eBooks · doi:10.1201/9780429508141-3 · Cited by 1
HIF-опосредованные механизмы взаимосвязи устойчивости к гипоксии и опухолевого роста
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521100018 · Cited by 1
The Effect of Lactic Acid on Mast Cell Function
Spence, A. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/kndf-gy69 · Cited by 1
Hypoxia, Anerobic Metabolism, and Interstitial Hypertension
Milosevic, M. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch9 · Cited by 1
Novel bioresponsive drug eluting microspheres to enhance chemoembolisation therapy
Ashrafi, K. (2014) · University of Brighton Repository (University of Brighton) · Cited by 1
Moon, E. J. (2010) · DukeSpace (Duke University) · Cited by 1
Exploiting the Bioenergetics of Disease-Causing Lymphocytes for Selective Immunomodulation.
Wahl, D. R. (2012) · Deep Blue (University of Michigan)
Elucidating the role of Cdc25A in hypoxia-mediated cell cycle arrest
de Oliveira, Q., & Pierre, E. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
McMahon, K. M. (2011) · Bradford Scholars (University of Bradford)
The relationship between HIF-1α and autophagy activity in the hypoxic environment of breast cancer
Mills, J. (2013) · SUNScholar (Stellenbosch University)
Regulated Extracellular Nucleotide Metabolism and Function at the Mucosa
MacManus, C. F., Eltzschig, H. K., & Colgan, S. P. (2010) · Springer eBooks · doi:10.1007/978-90-481-3435-9_8
The Leukemic Bone Marrow Microenvironment: Targeting Hypoxia with Hypoxia-Activated Prodrugs
Benito, J., Konopleva, M. Y., & Wilson, W. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1393-0_35
Ye, J. (2010) · ScholarlyCommons (University of Pennsylvania)
factor-2 in clear cell renal carcinoma
Kong, H., Lee, S., Beebe, K. E., Scroggins, B. T., Gupta, G. N., Jung, Y., Trepel, J. B., & Neckers, L. Μ. (2010)
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., Versteeg, R., Caron, H. N., Molenaar, J. J., Øra, I., Eva, A., et al. (2010)
EVOLUTION OF CYTOCHROME C OXIDASE SUBUNIT 4 IN RELATION TO HYPOXIA
Kocha, K. M. (2012) · QSpace (Queen's University Library)
DelNero, P. F., & Fischbach, C. (2016) · Nature Materials · doi:10.1038/nmat4549
Residual breast cancer metabolic phenotype after docetaxel treatment
Volpari, T. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Ambedkar, B. R. (2015)
Alkhanjaf, A. A. M. (2016) · UCL Discovery (University College London)
Review Role of angiogenesis on bone formation
Portal‐Núñez, S., Lozano, D., & Esbrit, P. (2012)
Metabolic Reprogramming and Hyaluronan Production in Cancer Stem Cells
Izumikawa, T., & Itano, N. (2018) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1713.1e
Investigating the role of the apelinergic system in glioblastoma
Venkatesh, V. S. (2018) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17134046
Role of Selected Transcription Factors in Pancreatic and Colorectal Cancer Growth and Metastasis
Peela, S., Dariya, B., & Nagaraju, G. P. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-5471-1_12
Rahayu, T. S. M., Gondhowiardjo, T. D., Artini, W., & Wanandi, S. I. (2020) · Medical Journal of Indonesia · doi:10.13181/mji.oa.203405
The expression of neuroglobin in astrocytoma
Zhang, H. Q. G., ZhangMingyuan, L., & Guan, L. (2012)
Dinç, S., Kılıç, O. N., Kırnap, E., Mavcioğlu, İ., Saraç, N., Sefer, S., Şenyuva, M. A., Al-Beyati, E. S. M., Doğan, Ö., Hayme, S., et al. (2022) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2021.97659
Ohno, N., Lei, T., Huang, Z., Sakoh, T., Saitoh, Y., & Ohno, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55723-4_52
Investigating the role of the apelinergic system in glioblastoma
Venkatesh, V. S. (2018) · doi:10.26686/wgtn.17134046.v1
Singh, J. C., & Zagzag, D. (2014) · Molecular pathology library · doi:10.1007/978-1-4939-1830-0_14
Josson, S., Nomura, T., Lin, J., Huang, W., Wu, D., Zhau, H. E., Zayzafoon, M., Weizmann, M. N., Gururajan, M., & Chung, L. W. K. (2023) · doi:10.1158/0008-5472.c.6502796.v1
Hu, Q., Qin, Y., Ji, S., Shi, X., Dai, W., Fan, G., Li, S., Xu, W., Liu, W., Liu, M., et al. (2023) · doi:10.1158/0008-5472.c.6513193.v1
Sasajima, J., Mizukami, Y., Sugiyama, Y., Nakamura, K., Kawamoto, T., Koizumi, K., Fujii, R., Motomura, W., Sato, K., Suzuki, Y., et al. (2023) · doi:10.1158/0008-5472.c.6499997.v1
Peña, C. M., Lee, A. H., Frare, M. F., Ghosh, D., & Dawson, M. (2023) · Current cancer research · doi:10.1007/978-3-031-22802-5_4
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.24.573250
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.1
Avaliação imuno-histoquímica das expressões de LOX, LOXL2 e HIF1A em tumores mamários caninos
Daniel, J. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.74.2023.tde-23022024-085638
Sun, Z., Zhang, Q., Yuan, W., Li, X., Chen, C., Guo, Y., Shao, B., Dang, Q., Zhou, Q., Wang, Q., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13269900
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.2
Metabolic Reprogramming of Clear Cell Renal Cell Carcinoma and Its Clinical Significance
周, 文. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451486
BCKDK, A Novel Hypoxia-Responsive Kinase That Exacerbates Cerebral Ischemia Injury
Liao, B., Zhang, F., Han, C., Yi, X., Zhang, Z., Jin, L., Geng, L., Wong, S. S. C., Hoo, R. L. C., Geng, L., et al. (2026) · Stroke · doi:10.1161/strokeaha.125.053856
Angiogenesis and the Tumor Microenvironment
Murphy, J. F. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_87
Oncostatin M induces epigenetic reprogramming in renal cell carcinoma-associated endothelial cells
Nguyen-Tran, H.-H., Nguyen, T.-N., & Hsu, T. (2025) · Communications Biology · doi:10.1038/s42003-025-08907-x
Taming Bacterial Toxins into an Anticancer Platform
Yang, C., & Chen, C. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152976
Offer, S., Menard, J. A., Pérez, J. E., de Oliveira, K. G., Indira Chandran, V., Johansson, M. C., Bång-Rudenstam, A., Siesjö, P., Ebbesson, A., Hedenfalk, I. A., et al. (2019) · Figshare · doi:10.6084/m9.figshare.8245394
Fox, S. B., Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12879662
Offer, S., Menard, J. A., Pérez, J. E., de Oliveira, K. G., Indira Chandran, V., Johansson, M. C., Bång-Rudenstam, A., Siesjö, P., Ebbesson, A., Hedenfalk, I. A., et al. (2019) · Figshare · doi:10.6084/m9.figshare.8245379
Fox, S. B., Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12879665
Offer, S., Menard, J. A., Pérez, J. E., de Oliveira, K. G., Indira Chandran, V., Johansson, M. C., Bång-Rudenstam, A., Siesjö, P., Ebbesson, A., Hedenfalk, I. A., et al. (2019) · Figshare · doi:10.6084/m9.figshare.8245412
Offer, S., Menard, J. A., Pérez, J. E., de Oliveira, K. G., Indira Chandran, V., Johansson, M. C., Bång-Rudenstam, A., Siesjö, P., Ebbesson, A., Hedenfalk, I. A., et al. (2019) · Figshare · doi:10.6084/m9.figshare.8245403
Offer, S., Menard, J. A., Pérez, J. E., de Oliveira, K. G., Indira Chandran, V., Johansson, M. C., Bång-Rudenstam, A., Siesjö, P., Ebbesson, A., Hedenfalk, I. A., et al. (2019) · Figshare · doi:10.6084/m9.figshare.8245388
Combined therapies of antithrombotics and antioxidants delay in silico brain tumor progressionPreprint
Mart\'inez-Gonz\'alez, A., Durán‐Prado, M., Calvo, G. F., Alcain, F. J., P\'erez-Romasanta, L. A., & Pérez‐García, V. M. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1401.2397
Zebrafish pkm activates the Hif-1α signaling pathway and promotes metabolic reprogramming
Zhang, W., Liu, D., Zhou, J., Zu, C., Li, Y., Liu, C., Sun, X., Lu, L., & Liu, Y. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153543
Recent advances in purpose-built 3D bioprinted cancer models for drug development
Ramos, L., Robinson, M., Lallous, N., Flannigan, R. K., & Daugaard, M. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2642320 · Cited by 1
Hétérogénéité métabolique des gliomes : apport de la spectroscopie RMN HRMAS
Bund, C. (2020) · theses.fr (ABES) · doi:10.70675/2f880f7az9a01z463fz9f4az0dcaad5fcf59
Long-term regulation of colorectal cancer cells under mechanical stress
Mouelhi, M. (2023) · theses.fr (ABES) · doi:10.70675/c4c32dd5zfd5ez4187za887z25dd0c7e3452
AGAP1 and noncanonical GDP binding regulate triple-negative breast cancer development
Zhang, Y., Zhang, S., Deng, X., Cheng, N., Wang, J., Huang, H., Zhuo, Z., Ye, S., Yu, X., Li, Z., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06196-z
Xu, C., Ji, K., Li, H., Zhang, J. Y., Wu, M., Chen, C., Niu, R., Sun, Y., & Liu, C. (2026) · Scientific Reports · doi:10.21203/rs.3.rs-9650845/v1
Hydrostatic pressure activates HIF ‐1α via β‐catenin to promote stemness in breast cancer cells
Zhai, D., Xu, Y., Ma, J., Duangrat, R., Yan, C., Liang, J., Wei, H., Jiang, B., & Li, T. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70267
DNA methylation and chromatin modifications-updates based on chromatin modifiers
Sepehri, Z., Beacon, T. H., Osman, F. D. S., Jahan, S., & Davie, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15572-7.00002-4
Nguyen, T. V., & Hsu, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136021 · Cited by 1
何光洲, Zhang, N., Xun, D., He, N., Chen, X., & Yang, X. (2026) · Gene · doi:10.1016/j.gene.2026.150476
Deng, R., Wang, B., Zou, M., Mao, K., Shang, J., Qiu, J., Zhou, J., Xu, H., Ma, X., Wang, Y., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-00986-0
Jeon, J., Baek, H. S., Park, K., Park, M., Heo, N. H., Cheon, S., Kim, G., & Kim, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209134
Singh, D. D., Yadav, D. K., & Shin, D. (2026) · Antioxidants · doi:10.3390/antiox15111414
Role of p53 in Adaptation to the Tumor Microenvironment
Mendoza, E. E. (2010) · UA Campus Repository (The University of Arizona)
Metadata
- Authors
- Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Semenza, Gregg L.
- ORCID
- Semenza, Gregg L.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 12-16
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2102416115
- Cited by
- 469
- References
- 67
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 14 · 2021: 28 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 29 · 2016: 36 · 2015: 32 · 2014: 33 · 2013: 35 · 2012: 35
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Cancer Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-1, cancer metabolism, tumor hypoxia, VHL gene, glucose transport, glycolysis, mitochondrial metabolism, reactive oxygen species, HIF-1 target genes, metabolic reprogramming, cancer therapy
- MeSH terms
- Animals, Glycolysis, Humans, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review